NeoThelium FT treatment for chronic pressure ulcers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an open‑label, prospective case series conducted at multiple centers where all participants receive weekly NeoThelium FT applications in addition to standard of care. Eligible adults have stage 2–3 pressure ulcers on the pelvis or lower extremity measuring between 1 and 30 cm2, are free of infection, and meet vascular perfusion criteria; use of offloading and negative pressure wound therapy is required when indicated. Investigators will follow enrolled patients on the scheduled visits to record wound healing outcomes and safety events. As a post‑marketing study, collected data will also support insurance reimbursement decisions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Male or Female, 18 years of age or older
2. Subject has a medical diagnosis of Pressure Injury/Ulcer located on the pelvis or lower extremity
3. Subject has a Pressure Injury/Ulcer Stage 2 or 3 without infection
4. Index ulcer is a minimum of 1cm2 and a maximum of 30cm2 at first treatment visit
5. Index ulcer has a depth of ≤ 1cm2, and subject is compliant to use continuous NPWT with 75-100mmHg, at the providers discretion
6. Index ulcer has a depth of \> 1cm2, and subject is compliant to use continuous NPWT with 75-100mmHg
7. Pressure Injury/Ulcer is treated with offloading therapy while standing, sitting and lying down (if applicable to wound location) for 7 days prior to the first treatment visit
8. Adequate circulation of ulcer, if located on the lower extremity, demonstrated by an ABI of \>0.7 and \<1.3, or TBI of \>0.6 within 30 days prior to the first treatment visit
9. Index ulcer is free of infection prior to the first treatment visit and during screening phase.
10. Index ulcer is free of necrotic debris prior to NeoThelium FT application
11. Female subjects of childbearing potential having a negative pregnancy test prior to the first treatment visit
12. Subject is able and willing to follow the protocol requirements
13. Subject had signed informed consent
14. If 2 or more ulcers are present, the ulcers must be separated by at least 2 cm

Exclusion Criteria:

1. Subject has a known life expectancy of \<1 year
2. Subject is unable to comply with protocol treatment
3. Subject has major uncontrolled medical disorders in the opinion of the investigator, such as serious cardiovascular, renal, liver, pulmonary, autoimmune, palliative care, or inherited blood disorders that may affect wound healing in the opinion of the investigator
4. Subject actively being treated for malignant disease or history of malignancy or radiation therapy at the site of wound
5. Subject has comorbid conditions that may compromise subject safety in the opinion of the investigator
6. Known contraindications to tissue-engineered allograft
7. Concurrent participation in alternative clinical trial that involves investigational drug or product interfering with wound treatment and/or healing
8. Subject is pregnant or breastfeeding
9. Subject with history of immunosuppressant treatment (systemic corticosteroids \>10mg daily dose), cytotoxic chemotherapy, or topical steroid application to the ulcer surface for \>14 days duration within 30 days prior to the first treatment visit; or anticipated use of the above during the course of the study
10. Wound previously treated with CAMPs, tissue engineered, or scaffold materials within 30 days prior to the first treatment visit
11. Pressure Injury/Ulcer of Stage 4 or active osteomyelitis
12. Wound depth with visible exposed bone
13. HBOT within 14 days prior to the first treatment visit
14. Revascularization surgery on the index ulcer leg within 30 days of screening phase
15. Index ulcer suspicious of neoplasm in the opinion of the investigator

Where it's running

• MedCentris of Bossier City
  Bossier City, Louisiana, United States Recruiting
• MedCentris of Rayville
  Rayville, Louisiana, United States Not yet recruiting

Study contacts

• Study coordinator: Angelina Ferguson, DNP
• Email: dr.aferguson@sygnola.com
• Phone: 986-629-4013

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Artificial Intelligence-Supported Pressure Injury Prevention in ICU Patients

  This study tests PRESS AI, a mobile app, to help nurses prevent and manage pressure injuries in adult ICU patients by guiding risk and wound assessment and care decisions.

  Recruiting Ankara Yildirim Beyazıt University · Ankara, Ankara · NCT07779395

• Paraffin oil to protect skin from tourniquet damage during upper limb surgery

  This trial will try applying topical paraffin oil to the skin of adults having elective upper extremity surgery to see if it prevents tourniquet-related redness, blisters, or abrasions.

  Recruiting Istanbul Medipol University Hospital · Istanbul · NCT07523958

• Zinc oxide vs MEBO for stage 2 pressure ulcers

  This trial tests whether applying zinc oxide or MEBO ointment heals stage 2 pressure ulcers faster in hospitalized patients.

  Recruiting Phase 4 King Abdullah Medical City · Mecca, Western Reagan and 1 other locations · NCT07193849

• Cellular, acellular, and matrix wound products plus standard care for nonhealing stage 3–4 pressure ulcers

  This study will try several cellular, acellular, and matrix-like wound products with standard care to see if adults with nonhealing stage 3–4 pressure ulcers heal more completely over 20 weeks than with standard care alone.

  Recruiting Phase 4 Tiger Biosciences, LLC. · Monroeville, Pennsylvania · NCT06999590

• Standardized laryngeal mask airway placement with cuff pressure monitoring for older adults

  This tests whether using a cuff pressure monitor when placing a laryngeal mask airway reduces airway-related adverse reactions in older adults having elective surgery.

  Recruiting First Affiliated Hospital of Chongqing Medical University · Chongqing, Chongqing Municipality · NCT06954857

• Using a special bed to reduce pressure injuries in critically ill patients

  This study is testing if a special bed can help prevent pressure injuries in critically ill adults and elderly patients on ventilators better than regular repositioning methods.

  Recruiting University of Sao Paulo General Hospital · São Paulo, São Paulo · NCT06819943

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.